+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Cytokine Market - Growth, Trends and Forecasts (2017 - 2022)

  • ID: 4402769
  • Report
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 4


  • Abbvie
  • Biocon
  • Biotechne
  • Glaxosmithkline
  • Johnson & Johnson
  • Novartis
  • MORE
In 2016, the global cytokine market was valued at USD XX million. Considering the historical trend and possible future developments, the market is projected to reach USD XX million by 2022, registering a CAGR of XX%, during 2017-2022 (the forecast period).

Cytokines are a group of immune-mediators, which comprises of TNF-superfamily members, such as, interferons, interleukins, and chemokines. Several cytokines and their receptors have been used to treat various diseases that include rheumatoid arthritis (RA), type I diabetes, multiple sclerosis (MS).


The cytokine market is a flourishing market. The multi-faceted applications of cytokines in various domains, like prophylactic, diagnostic, and therapeutic use, to cure various diseases, has widened the horizons of the cytokine market, globally. Recent studies have shown promising contribution of cytokines in stem cell therapy, which has been a stimulating factor for investors to invest.

Inflammatory cytokines are a potential biomarker for neonatal sepsis, which is a growing cause of neonatal morbidity and mortality, worldwide. Moreover, it is a significant and viable option for cancer therapy with minimal side effects, when compared to chemotherapy and radiation.


Though cytokines are extremely potent, they are designed to work, locally, and, thus, have short half-lives, something that necessitates prolonged administration. This factor condemns cytokine therapies among patients and doctors. In addition, an efficient way to maintain proper cytokine dose over a prolonged time period has not been worked out yet. This problem gets worse when cytokine doses are not given systemically.

Binding to surface receptors on cells, cytokines trigger a variety of biochemical cascades, which ultimately alter gene expression within those cells. In the interim, cancer immunotherapy has improved in areas like specificity, where cytokine therapy is not as effective and is perhaps it’s biggest drawback.

Apart from the drawbacks of cytokine therapy, the diagnostic equipment, like PCR, require skilled labor, extensive laboratory infrastructure, and expensive reagents. These requirements fuel the need for heavy investment, thus, restraining the market.

Market Segmentation

The global cytokine market has been segmented on the basis of cytokine type (Tumour Necrosis Factor (TNF), Interleukins (IL), Interferon (IFN), Epidermal Growth Factor (EGF), therapeutic application (Cancer & Malignancies, Asthma/Airway Inflammation, Arthritis, and ‘Others’), and region (North America, Europe, Asia-Pacific, the Middle East & Africa, and South America).

The report provides a detailed overview of the use of each cytokine type and their respective devices, along with in-depth analysis and company profiles of the major players and a clear picture of the competitive landscape that currently exists in the market.

The Key Players in the Global Cytokine Market Include:

Johnson & Johnson
Bayer Healthcare Pharmaceuticals
Thermo Fisher Scientific

Key Deliverables

Market analysis, with region specific assessments and competition analysis
Market definition along with the identification of key drivers, restraints, opportunities, and challenges
Identification of factors instrumental in the changing the market scenario, rising prospective opportunities, and identification of key companies that influence the market on the global and regional scale
Extensively researched competitive landscape section with company profiles of the key players, with the analysis of their current strategic interests and key financial information
Identification and analysis of the macro and micro factors that affect the market
Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped

Related Topics: Asia-Pacific Cancer Therapy Market - Growth, Trends, and Forecasts (2016- 2021)
Note: Product cover images may vary from those shown
2 of 4


  • Abbvie
  • Biocon
  • Biotechne
  • Glaxosmithkline
  • Johnson & Johnson
  • Novartis
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product & Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increased Acceptance in Cancer Therapy
6.1.2 Potential Biomarker for Neonatal Sepsis
6.1.3 Potential Contribution in Stem Cell Therapy
6.2 Market Restraints
6.2.1 Extensive Investments
6.2.2 Lacks Specificity
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 Segmentation-By Cytokine Type
7.1.1 Tumor Necrosis Factor-TNF
7.1.2 Interleukins-Il
7.1.3 Interferons-IFN
7.1.4 Epidermal Growth Factor-EGF
7.1.5 Others
7.2 Segmentation-By Therapeutic Application
7.2.1 Cancer
7.2.2 Asthma & Airway Inflammation
7.2.3 Arthritis
7.3 Segmentation-By Geography
7.3.1 North America United States Canada Mexico
7.3.2 Europe France Germany United Kingdom Italy Spain Rest of the Europe
7.3.3 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest of the Asia-Pacific
7.3.4 Middle East & Africa GCC South Africa Rest of the Middle East & Africa
7.3.5 South America Brazil Argentina Rest Of the South America

8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches

9. Key Players
9.1 Glaxosmithkline
9.2 Novartis
9.3 Roche
9.4 Pfizer
9.5 Sanofi
9.6 Bayer Healthcare Pharmaceuticals
9.7 Thermo Fisher Scientific
9.8 Biocon
9.9 Biotechne
9.10 Abbvie
9.11 Johnson & Johnson

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Glaxosmithkline
  • Novartis
  • Roche
  • Pfizer
  • Sanofi
  • Bayer Healthcare Pharmaceuticals
  • Thermo Fisher Scientific
  • Biocon
  • Biotechne
  • Abbvie
  • Johnson & Johnson
Note: Product cover images may vary from those shown